51. [Superselective intra-arterial chemotherapy in breast cancer].
- Author
-
Görich J, Hasan I, Sittek H, Jakschik J, Werner H, Hartlapp HJ, and Reiser M
- Subjects
- Adult, Aged, Angiography, Breast Neoplasms diagnostic imaging, Female, Humans, Infusions, Intra-Arterial, Mammary Arteries, Middle Aged, Mitoxantrone adverse effects, Monitoring, Physiologic methods, Neoplasm Recurrence, Local diagnostic imaging, Tomography, X-Ray Computed, Breast Neoplasms drug therapy, Mitoxantrone administration & dosage, Neoplasm Recurrence, Local drug therapy
- Abstract
Forty-two patients with locally advanced breast cancer (n = 8) or recurrent breast cancer (n = 34) received regional chemotherapy (mitoxantrone 25 mg/m2 per 24 h) via the internal mammary artery or other vessels of the subclavian artery. To prevent artery thrombosis 500-1000 U heparin per hour were administered i.v. Tumour perfusion was monitored by intra-arterial angio-CT. Remission rates (CR + PR) were 100% (primary breast cancer) and 89% (recurrent tumours), respectively. Intra-arterial chemotherapy was well tolerated. No complications were noted.
- Published
- 1993